These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 269294)

  • 1. [Leukapheresis. a. Treatment of chronic myelogenous leukemia].
    Kobayashi S
    Rinsho Ketsueki; 1977 May; 18(5):615-20. PubMed ID: 269294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leukapheresis of patients with acute leukemia and chronic myelogenous leukemia (author's transl)].
    Kawashima K; Ueda R
    Rinsho Ketsueki; 1977 May; 18(5):620-6. PubMed ID: 269295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leukapheresis in chronic myelocytic leukemia].
    Shinohara Y; Matsubuchi T; Kawagoe H
    Rinsho Ketsueki; 1982 Oct; 23(10):1645-50. PubMed ID: 6961245
    [No Abstract]   [Full Text] [Related]  

  • 4. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
    Shafique S; Bona R; Kaplan AA
    Ther Apher Dial; 2007 Apr; 11(2):146-9. PubMed ID: 17381536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic cytapheresis in hairy cell leukemia and chronic myelocytic leukemia].
    Yoshida Y; Yoshida H; Yamagishi M; Hiraoka A; Uchida M
    Rinsho Ketsueki; 1982 Oct; 23(10):1656-60. PubMed ID: 6961246
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic applications of hemapheresis].
    Huestis DW; Pineda AA
    Sangre (Barc); 1982; 27(6):1059-72. PubMed ID: 6764036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis as an auxiliary method in the immunotherapy of chronic myelosis].
    Smálik S; Filová J
    Cas Lek Cesk; 1970 Mar; 109(11):246-50. PubMed ID: 5270441
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological effects of repeated leukapheresis of patients with chronic myelogenous leukemia.
    Vallejos CS; McCredie KB; Brittin GM; Freireich EJ
    Blood; 1973 Dec; 42(6):925-33. PubMed ID: 4519104
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems on the treatment of chronic myelogenous leukemia (CML)--from the point of the blast crisis (author's transl)].
    Kitajima K
    Rinsho Ketsueki; 1978 Apr; 19(4):386-91. PubMed ID: 279725
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two busulfan-resistant cases of CML (chronic myelogenous leukemia) with good response to alpha-interferon treatment].
    Ogura H; Shirafuji N; Kumakawa T; Matsuda S; Horiuchi N; Kodo H; Fujii H; Asano S; Miwa S; Shinohara T
    Rinsho Ketsueki; 1987 Sep; 28(9):1599-604. PubMed ID: 3481405
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukapheresis in the management of chronic leukemia.
    Fortuny IE; Crandall L; McCullough J; Theologides A; Kennedy BJ
    Minn Med; 1973 Aug; 56(8):674-6. PubMed ID: 4517650
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic leukapheresis in hairy cell leukemia.
    Mielke CH; Dobbs CE; Winkler CF; Yam LT
    Arch Intern Med; 1982 Apr; 142(4):700-2. PubMed ID: 7073413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic leukapheresis in chronic granulocytic leukemia and term twin pregnancy].
    Morales Polanco MR; Ambriz Fernández R; Gutiérrez Sandoval J; Delgado Sánchez B
    Ginecol Obstet Mex; 1985 Oct; 53():287-90. PubMed ID: 3866727
    [No Abstract]   [Full Text] [Related]  

  • 15. [Successful prevention of cerebrovascular attack in chronic myelocytic leukemia with cytapheresis].
    Imai J; Hayashi K; Nakanishi K; Murakami H; Hato T
    Rinsho Ketsueki; 1983 Jul; 24(7):944-6. PubMed ID: 6579321
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukapheresis for control of chronic myelogenous leukemia during pregnancy.
    Fitzgerald D; Rowe JM; Heal J
    Am J Hematol; 1986 Jun; 22(2):213-8. PubMed ID: 3458363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985.
    Suzuki H; Ota K; Ohno R; Masaoka T; Shibata H; Kimura I; Amaki I; Miura Y; Uzuka Y; Kawato M
    Jpn J Clin Oncol; 1989 Dec; 19(4):338-47. PubMed ID: 2607637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulocytic leukemia in pregnancy. A case report.
    Nolan TE; Ross WB; Caldwell C
    J Reprod Med; 1988 Jul; 33(7):661-3. PubMed ID: 3172066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L-5 protocol: intensive treatment for patients with chronic myeloid leukemia.
    Gee TS; Cunningham I; Dowling MD; Chaghanti R; Clarkson BD
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):289-93. PubMed ID: 282899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome?
    Melillo L; Specchia G; Ferrara F; Minervini MM; Pastore D; Carella AM
    Haematologica; 2003 Jun; 88(6):715-8. PubMed ID: 12801851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.